HAE

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Haemonetics Corp.

Haemonetics is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services.
CEO
Christopher Simon
Employees
2708
Headquarters

125 Summer Street
Boston, Massachusetts 02110
Phone: 17818487100
www.haemonetics.com

News

Haemonetics gets FDA okay for TEG 6s hemostasis cartridge
Apr 04, 2024 21:01pm

No summary available.


Source:Seeking Alpha
Haemonetics Receives FDA Clearance for New TEG 6s Global Hemostasis - HN Cartridge
Apr 04, 2024 10:30am

BOSTON, April 4, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, announced today that it has received 510(k) clearance from the U.S. Food and Drug…


Source:PR Web
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
Apr 04, 2024 10:30am


Source:Kwhen Finance
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge | HAE Stock News
Apr 04, 2024 10:30am

Haemonetics receives FDA clearance for TEG® 6s hemostasis analyzer system Global Hemostasis-HN assay cartridge, expanding testing capabilities for heparinized patients in cardiovascular and liver surgeries.


Source:Stock Titan
Haemonetics Corporation: Improved Performance, Another Bolt-On Deal
Mar 06, 2024 22:38pm

No summary available.


Source:Seeking Alpha
Haemonetics to buy Attune Medical for $160M
Mar 05, 2024 11:37am

No summary available.


Source:Seeking Alpha
Haemonetics to acquire Attune Medical for $160 million
Mar 05, 2024 11:07am

https://www.investing.com/news/stock-market-news/haemonetics-to-acquire-attune-medical-for-160-million-93CH-3324247


Source:Investing.com
Haemonetics Announces Definitive Agreement to Acquire Attune Medical | HAE Stock News
Mar 05, 2024 11:00am

Haemonetics Corporation (NYSE: HAE) announces acquisition of Attune Medical, a manufacturer of ensoETM esophageal cooling device, for $160 million upfront with additional contingent consideration. The deal aims to enhance Haemonetics'' presence in the electrophysiology market and improve patient outcomes.


Source:Stock Titan
Haemonetics Corporation: Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Mar 05, 2024 11:00am

BOSTON, March 5, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical products and solutions to drive better patie…


Source:Finanz Nachrichten
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
Mar 05, 2024 11:00am

BOSTON, March 5, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical products and solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to acquire…


Source:PR Newswire